This is a demo store. No orders will be fulfilled.
首页
400-620-6333
应用
选项
-
Vonlerolizumab (anti-OX40)关联靶标: TNFRSF4简短描述: Purity≥95% (SDS-PAGE&SEC); Endotoxin Level≤1.0EU/mg; Human IgG1-EM; CHO; ELISA, FACS, Functional assay, Animal Model; Unconjugated种属反应性: 人(Human) 亚型: Human IgG1-EM宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1638935-72-4
-
Litifilimab (anti-CLEC4C)关联靶标: CLEC4C种属反应性: 人(Human) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 2407378-48-5
-
Pritumumab (anti-Vimentin)关联靶标: VIM种属反应性: 人(Human) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 499212-74-7
-
Porgaviximab (anti-EBOV)种属反应性: 扎伊尔埃博拉病毒(Zaire Ebola virus) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1792982-55-8
-
Larcaviximab (anti-EBOV)种属反应性: 扎伊尔埃博拉病毒(Zaire Ebola virus) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 1792982-56-9
-
Lesabelimab (anti-PD-L1)关联靶标: CD274种属反应性: 人(Human) 亚型: Human IgG1宿主种属: 人(Human) 偶联: UnconjugatedCAS号: 2475402-56-1
-
T4 RNA 连接酶 2，截短型种属: 肠杆菌噬菌体T4(Enterobacteria phage T4) Accession #: P32277.1表达系统: E. coli生物活性: 200 units is defined as the amount of enzyme required to give 80% ligation of a 31-mer RNA to the pre-adenylated end of a 17-mer DNA (Universal miRNA Cloning Linker) in a total reaction volume of 10 µl in 1 hour at 25℃.
-
T4 RNA 连接酶 2，截短突变型种属: 肠杆菌噬菌体T4(Enterobacteria phage T4) Accession #: P32277.1表达系统: E. coli生物活性: 200 units is defined as the amount of enzyme required to give 80% ligation of a 31-mer RNA to the pre-adenylated end of a 17-mer DNA (Universal miRNA Cloning Linker) in a total reaction volume of 20µl in 1 hour at 25℃.
